Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Not yet recruiting · NCT07775482 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperkalemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, acute kidney injury, chronic renal failure syndrome, kidney disorder, kidney failure, metabolic disease, urinary system disorder | Not yet recruiting | Not applicable | 2026-08-20 | NCT07775482 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jean-Maxime Côté | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier de l'Université de Montréal | Montreal | Canada | 13 |